Literature DB >> 11045689

Mediastinal lymphadenopathy in pulmonary fibrosis: correlation with disease severity.

J I Jung1, H H Kim, Y J Jung, S H Park, J M Lee, S T Hahn.   

Abstract

OBJECTIVE: To evaluate the relationship between mediastinal lymph node enlargement and disease severity score in patients with pulmonary fibrosis.
MATERIALS AND METHODS: A retrospective study included 30 patients with pulmonary fibrosis: idiopathic pulmonary fibrosis (n = 25), usual interstitial pneumonia (UIP) associated with collagen vascular disease (n = 4), and UIP associated with hepatitis C (n = 1). Disease severity was determined by a computed tomography (CT) scoring system. Each patient's lobe was scored by two radiologists on a scale of 0-5 for both ground glass opacity (GGO) and fibrosis. The presence, number, and sites of enlarged nodes (short axis > or = 10 mm) were assessed. CT severity scores were compared with total number of enlarged lymph nodes (L/Ns) and short axis diameter of the largest L/N (LLN). According to each severity score, patients were divided into two groups: the GGO-predominant group (n = 10) and the fibrosis-predominant group (n = 20). Total numbers of enlarged L/Ns and short axis diameter of LLN were compared in each group.
RESULTS: Enlarged mediastinal L/Ns were present in 86%. Total severity score, GGO score, and fibrosis score strongly correlated with total number of enlarged L/Ns (p<0.05). Total severity score and GGO score correlated well with short axis diameter of LLN; however, the fibrosis score did not correlate with the short axis diameter of LLN. In respect to total number of enlarged L/Ns, the difference between the GGO group and fibrosis group was not apparent. In respect to the short axis diameter of LLN, the GGO group LLN was larger in diameter than the fibrosis group LLN (p<0.05).
CONCLUSION: The greater the severity score of pulmonary fibrosis, the larger the total number of enlarged L/Ns. Those patients with more GGO had larger lymph nodes.

Entities:  

Mesh:

Year:  2000        PMID: 11045689     DOI: 10.1097/00004728-200009000-00007

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  7 in total

1.  Prognosticating Outcomes in Interstitial Lung Disease by Mediastinal Lymph Node Assessment. An Observational Cohort Study with Independent Validation.

Authors:  Ayodeji Adegunsoye; Justin M Oldham; Catherine Bonham; Cara Hrusch; Paul Nolan; Wesley Klejch; Shashi Bellam; Uday Mehta; Kiran Thakrar; Janelle Vu Pugashetti; Aliya N Husain; Steven M Montner; Christopher M Straus; Rekha Vij; Anne I Sperling; Imre Noth; Mary E Strek; Jonathan H Chung
Journal:  Am J Respir Crit Care Med       Date:  2019-03-15       Impact factor: 21.405

2.  Mediastinal lymphadenopathy reflecting disease activity in an infant with chronic pneumonitis of infancy associated with surfactant protein C mutation: a case report and literature review.

Authors:  Sang Hoon Lee; Young Ok Kim; Eun Lee; In Seok Jeong; Yoo-Duk Choi; Hwa Jin Cho
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

Review 3.  Extra-cardiac findings in cardiovascular magnetic resonance: what the imaging cardiologist needs to know.

Authors:  Jonathan C L Rodrigues; Stephen M Lyen; William Loughborough; Antonio Matteo Amadu; Anna Baritussio; Amardeep Ghosh Dastidar; Nathan E Manghat; Chiara Bucciarelli-Ducci
Journal:  J Cardiovasc Magn Reson       Date:  2016-05-09       Impact factor: 5.364

Review 4.  Imaging in idiopathic pulmonary fibrosis: diagnosis and mimics.

Authors:  Bruno Hochhegger; Edson Marchiori; Matheus Zanon; Adalberto Sperb Rubin; Renata Fragomeni; Stephan Altmayer; Carlos Roberto Ribeiro Carvalho; Bruno Guedes Baldi
Journal:  Clinics (Sao Paulo)       Date:  2019-02-04       Impact factor: 2.365

5.  Thoracic lymphadenopathies in diffuse systemic sclerosis: an observational study on 48 patients using computed tomography.

Authors:  Arthur Renaud; Raphael Pautre; Olivier Morla; Aurélie Achille; Cécile Durant; Olivier Espitia; Eric Frampas; Christian Agard
Journal:  BMC Pulm Med       Date:  2022-01-25       Impact factor: 3.317

Review 6.  Role of EBUS-TBNA in Non-Neoplastic Mediastinal Lymphadenopathy: Review of Literature.

Authors:  Valentina Scano; Alessandro Giuseppe Fois; Andrea Manca; Francesca Balata; Angelo Zinellu; Carla Chessa; Pietro Pirina; Panos Paliogiannis
Journal:  Diagnostics (Basel)       Date:  2022-02-16

7.  Impact of mediastinal lymph node enlargement on the prognosis of idiopathic pulmonary fibrosis.

Authors:  Sooim Sin; Kyung Hee Lee; Jee Hye Hur; Sang-Hoon Lee; Yeon Joo Lee; Young-Jae Cho; Ho Il Yoon; Jae Ho Lee; Choon Taek Lee; Jong Sun Park
Journal:  PLoS One       Date:  2018-07-25       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.